Delivery Order SPE2DR25D1202-SPE2DR26F71UF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Lisdexamfetamine 60 mg capsules (90-count units) valued at $2,794.14 under a firm fixed-price contract type. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) with a ceiling value of $3,887.69. This competitively awarded, firm fixed-price delivery order is set to complete by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100 count) with a ceiling value of $8,326.56 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 23, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued against...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lisdexamfetamine 20 mg capsules (100-count units) under a firm fixed-price contract valued at $11,279.96. This non-competitive delivery order is expected to be completed by September 2, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count) with a ceiling value of $1,148.10. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,651.64. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count) with a contract value of $1,625.77 and an ultimate completion date of October 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Lisdexamfetamine 30 mg capsules (90-count units) under a firm fixed price contract with a ceiling value of $1,544.72. This non-set-aside delivery order is scheduled for completion by October 21, 2025, with performance taking place at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lisdexamfetamine 40 mg capsules in quantities of 100 units. This is a firm fixed price delivery order with a ceiling value of $1,480.44 and an ultimate completion date of August 7, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 30 mg capsules (100-count units) on September 3, 2025, with a ceiling value of $1,176.88 and ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under a larger...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71UFDelivery Order
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) valued at $4,178.96. This delivery order, which carries a firm fixed price and is scheduled for completion by October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was not designated as a set-aside contract and was competitively awarded to the pharmaceutical distributor, which maintains its corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 prime indefinite delivery vehicle (SPE2DX) with DLA Troop Support Medical extending through December 2026, which serves as a comprehensive global pharmaceutical support contract enabling the company to supply medications and medical commodities to military healthcare programs worldwide. The current delivery order for Lisdexamfetamine, a Schedule II controlled substance used in the treatment of attention deficit hyperactivity disorder, exemplifies the company's role in fulfilling specialized pharmaceutical procurement requirements for the Defense Health Agency and other federal healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/30/25 |